Position in NAGE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$292,043
-$91,732 QoQ
Shares Held
66,223
+9.7% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. NAGE ranks #203 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in NAGE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $292,043 | 66,223 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $383,775 | 60,342 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $532,994 | 57,127 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $788,875 | 54,745 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $353,342 | 51,209 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $304,284 | 57,304 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $201,144 | 55,108 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $150,444 | 55,108 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $136,764 | 39,300 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $56,199 | 39,300 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $57,378 | 39,300 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $61,701 | 39,300 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $60,129 | 39,300 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $66,024 | 39,300 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $27,675 | 22,500 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $37,575 | 22,500 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $131,049 | 53,272 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $133,413 | 35,672 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $229,933 | 36,672 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $250,355 | 25,391 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $170,716 | 18,278 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $135,331 | 28,194 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $66,942 | 16,694 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||